Revealing how phenytoin triggers liver damage and the potential protective effects of Balanites Aegyptiaca fruit extracts: Exploring Nrf2/MAPK/ Beclin-1 signaling pathways.


Journal

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 31 05 2023
revised: 24 07 2023
accepted: 31 07 2023
medline: 17 8 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

Phenytoin-induced liver injury (PHT ILII) is a serious condition that may necessitate discontinuation of the drug. This study investigates the mechanisms of PHT ILII and evaluates the protective effects of Balanites Aegyptiaca (BA) fruit extracts on the liver. We focus on the Nrf2/MAPK/NF-κB/Beclin-1 signaling pathways involved in oxidative stress and inflammation from drug-induced liver injury. Phytochemical analyses of BA fruit extracts (Bu-F and EA-F) are conducted. Molecular docking techniques explore the interaction between phenytoin (PHT) and the Nrf2/MAPK/NF-κB/Beclin-1 pathways. Thirty-six male rats are divided into Control, Bu-F, EA-F, PHT, Bu-F/PHT, and EA-F/PHT groups, and they are observed for 45 days. EA-F extract is rich in phenolics/flavonoids, while Bu-F extract mainly contains saponins.PHT ILII causes histological damage in liver tissues and affects Nrf-2, MAPK, TNF-α, IL-1β, Mcp-1, Beclin-1, iNOS expression, and liver function markers (ALT, AST, ALP). However, EA-F/Bu-F extracts effectively improve the histological structure and significantly reduce biochemical/immunohistochemical parameters, restoring them to near-normal levels. EA-F extract is particularly effective.In conclusion, the Nrf2/MAPK /Beclin-1 pathways play a critical role in the development of PHT ILII. BA fruit extracts show promise as hepato-protective agents, with the EA-F extract demonstrating superior efficacy. These results lay the groundwork for new treatments for PHT ILII and drug-induced liver injuries.

Identifiants

pubmed: 37541174
pii: S0753-3322(23)01056-9
doi: 10.1016/j.biopha.2023.115265
pii:
doi:

Substances chimiques

Phenytoin 6158TKW0C5
Plant Extracts 0
NF-E2-Related Factor 2 0
Beclin-1 0
NF-kappa B 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115265

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest It is stated by the authors that they have no competing interests. The funding, the content, and the drafting of this paper are all the exclusive responsibility of the authors.

Auteurs

Shaimaa M Azzam (SM)

Department of Biochemistry, Egyptian Drug Authority (EDA), Formerly National Organization for Drug Control and Research (NODCAR), Giza, Egypt. Electronic address: dr.shaimaaazzam5@gmail.com.

Marwa Refaat Abdel Khalek (MR)

Phytochemistry department, Egyptian Drug Authority (EDA), Formerly National Organization for Drug Control and Research (NODCAR), Giza 11221, Egypt. Electronic address: marwarefaat30683@gmail.com.

Amina A S Abdel Rahman (AAS)

Department of Zoology, Faculty of Women for Arts, Science, and Education, Ain Shams University, Asmaa Fahmy Street, Heliopolis, Cairo, Egypt. Electronic address: amina_abdelrahman@women.asu.edu.eg.

Amany Abdelhameid Osman (AA)

Department of Zoology, Faculty of Women for Arts, Science, and Education, Ain Shams University, Asmaa Fahmy Street, Heliopolis, Cairo, Egypt. Electronic address: amanyosman@women.asu.edu.eg.

Heba Mohammed Refat M Selim (HMRM)

Department of Pharmaceutical Sciences, Faculty of Pharmacy, AlMaarefa University, Diriyah 3713, Riyadh, Saudi Arabia; Microbiology and Immunology Department, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt. Electronic address: hebarefat1983@gmail.com.

Asmaa Fady Sharif (AF)

Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt; Clinical Medical Sciences Department, College of Medicine, Dar Al Uloom University, Riyadh 13314, Saudi Arabia. Electronic address: asmaa.sherif@med.tanta.edu.eg.

Yomna Ahmad El-Khattib (YA)

Physiology department Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: yomna.elkhattib@gmail.com.

Sameh Rabea (S)

Department of Pharmaceutical Sciences, Faculty of Pharmacy, AlMaarefa University, Diriyah 3713, Riyadh, Saudi Arabia. Electronic address: srabea@mcst.edu.sa.

Sahar K Ali (SK)

Department of Clinical Pharmacology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt. Electronic address: SKAly@medicine.zu.edu.eg.

Alshaymaa Darwish (A)

Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: Alshaymaa.Darwish@pharm.sohag.edu.eg.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH